The decision to treat an unruptured intracranial aneurysm involves a tradeoff between the immediate hazard and expense posed by treatment and the long-term risk of rupture. These decisions are unlikely to be sufficiently addressed by controlled trials for several reasons: there are few if any such trials in progress, the long duration of such trials compared with the rate of development of new techniques, and difficulty in generalizing the results of trials to individual patients with their numerous clinical details.
tific journals. This prevents updating or modifying the analyses after publication, when new clinical data and medical technology inevitably become available. 6) Decision analyses are usually performed with the aid of specialist software programs that are expensive and require training. It is not easy for readers to reproduce or adjust the results. 7) Sensitivity analysis is generally deterministic and limited to one-and two-way analyses. The impact of uncertainty in the input parameters is generally not expressed in the context of variance from the other parameters in the model.
We wanted to develop a clinical decision-analysis system that would address these limitations. Using the neurosurgical example of unruptured intracranial aneurysms, we describe a computer system for decision analysis that has the following features: it is interactive for the selection of input parameters, it is applicable to individual patients, it is probabilistic, it is easy to use and understand, it can be updated rapidly, it permits interactive multi-way probabilistic sensitivity analysis, and it can be easily transmitted via the Internet.
MATERIALS AND METHODS

Implementation of the System
The system for decision analysis that we propose is a computer program written in Visual Basic for Applications in which an Excel spreadsheet is used as the interface for clinicians (Excel; Microsoft Corp., Redmond, WA). The program is available as an email attachment (write to James.Gelder@swsahs.nsw.gov.au). The program creates statistical probability distributions for estimated clinical factors from user data inputs. Feedback is provided for the user about the distributions. The program is designed to perform probabilistic simulations and the outcome of the analysis is reported with a variety of graphs and summary statistics.
Decision Tree
There are three main branches of the decision tree for unruptured intracranial aneurysms (Fig. 1) . The lesion may be surgically treated, in which case the patient may die or may experience major or minor morbidity. The model described here assumes that after surgery the aneurysm is effectively obliterated and that there is no recurrence and rupture. The patient with an unruptured intracranial aneurysm may undergo observation, in which case there is a chance of rupture. If the aneurysm ruptures the patient may suffer a major or minor morbidity, or may die. If there is no rupture the patient continues to live a normal life. A patient with an unruptured intracranial aneurysm may be treated with endovascular techniques, in which case the decision-tree structure is similar to that pertaining to surgical treatment. The same assumptions about effective aneurysm obliteration and recurrence are made in the current model.
User Inputs
Initial demographic inputs include patient age, sex, and the discount rate for future life years. Inputs are required for the perceived QOL with major and minor disabilities ranging from 0 to 100%. The same format is used for entering the estimated outcomes of treatment or aneurysm rupture. Clinicians are required to supply a sample size and the numbers of patients with each outcome. For example, among 150 patients five died, 10 suffered a major permanent disability, and 15 suffered a minor permanent disability. The underlined numbers are entered by the clinician. Similar methods are used for entering the estimated rate of rupture of untreated aneurysms.
Calculations Related to Alternate Decisions
The program is equipped with Monte Carlo methods to simulate outcomes for each alternate decision for 10,000 patients. The outcomes are expressed as the difference in DQALYs. Bayesian methods with noninformative conjugate prior distributions are used to derive posterior distributions for the model parameters from the input data. These include Dirichlet distributions for the outcomes of treatment or aneurysm rupture (death, minor and major disability, and normal health) and a gamma distribution for the rate of rupture.
For each simulation, parameters are sampled that describe multinomial distributions for the outcomes of treatment and rupture. A rate is sampled for the annual rate of aneurysm rupture; it is assumed that the annual rupture rate is constant over time. From these parameters discrete events are simulated for individual outcomes, such as the outcome of treatment or the time to rupture. The age at death is randomly drawn according to the Australian life table for male or female patients. This age is the same for all decision branches and represents the age at death from causes unrelated to the aneurysm. The outcome of aneurysm rupture will worsen as the patient ages. The model N. Ghinea and J. M. van Gelder adjusts the outcome of aneurysm rupture in the future according to the age of the patient at the time of rupture. This adjustment was derived from a metaanalysis of five studies that describe the relationship between aneurysm rupture and age. 18, 19, 21, 26, 27 We chose discrete event simulation rather than Markov processes, which are commonly used in medical decision analysis. This was computationally more efficient, which was particularly useful for probabilistic sensitivity analysis. We wrote code for using random-number generators using Visual Basic for Applications.
Calculating the DQALYs
For illustrative purposes we describe the case of a patient whose lesion was managed with observation and who suffered an aneurysm rupture and survived it with a major morbidity. The time to rupture (tr) is sampled from an exponential distribution, the annual discount rate is r, and the time to death (td) is sampled from the life table. Because the aneurysm ruptured, tr was less than td. The QOL with a major morbidity is qMajor. The formula for calculating DQALYs for this outcome is as follows:
Model Outputs
The model generates DQALY values for the decision alternatives. For individual cases the program calculates the change in DQALYs between the decision alternatives. Statistical summary results include the mean, median, and 95th percentile limits for the change in DQALY values. Histograms show the distributions of the change in DQALY outcomes between the treatments. The DQALY survival curves show the percentage of patients surviving at a particular DQALY. This differs from normal survival curves, in which the percentage of patients surviving is plotted against full life years. The DQALY survival curve is identical to a standard survival curve when major and minor morbidity states are assigned a QOL of 100%.
Probabilistic Sensitivity Analysis
We used a second hierarchy for the decision model applied in probabilistic sensitivity analysis (Fig. 2) . In the higher level we took 1000 draws from the distributions of the parameters selected for sensitivity analysis. For each draw, in turn, we ran the standard decision analysis for 10,000 outcomes. The mean change in DQALYs was recorded. This may be regarded as a multi-way probabilistic sensitivity analysis for selected parameters. The parameters that are not selected are averaged out in the lower level of the simulation. The individual variations in the outcomes of the cases are also averaged out. The sensitivity analysis requires 10,000,000 simulated individual outcomes. The parameters used for the sensitivity analysis may be selected to be any single one or up to all of the parameters together.
Expected Value of Perfect Information
The EVPI is a summary statistic that describes the estimated cost of error in accepting the overall result of the decision analysis. 9 This is provided to quantify the results of the probabilistic sensitivity analysis. The rationale behind the EVPI is first, that information is valuable insofar as it is likely to influence the decision, and second, that the cost of a decision is measured by the value of the next-best alternative. The mean change in DQALYs (represented by the variable u) is the result of a lower-level simulation. The overall expected u, or E(u), can be separated into a positive component (A) and a negative component (B), as is illustrated in Fig. 3 . If A ϩ B is positive, the decision (for example, surgery) is supported by the model and the EVPI is ϪB. Further information that increases the expected value of A will not change the optimum decision. If A ϩ B is negative, the alternative (for example, observation) is supported and the EVPI is A.
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RESULTS
The data for a sample simulation are presented in Table  1 and the results are in Table 2 . This contains information on a 45-year-old woman without risk factors or comorbidities who had a 10-mm anterior circulation aneurysm and no history of treatment for ruptured lesions. Estimates are derived from the International Study of Unruptured Intracranial Aneurysms. 30 The data used for input and distributions for the aneurysm rupture rate, the outcome of treatment, and the outcome of aneurysm rupture used for the simulations are specified in Table 1 .
The illustrative case is presented with data from a single source that is widely available. This data source has been selected only for the purpose of illustration of the model and we do not wish to endorse or criticize the study. The DQALY survival plots are shown in Fig. 4 for the endovascular, surgical, and observation treatment decisions. The QOL considerations for patients with major or minor disabilities are important interactive parameters that reflect the values of the decision maker or the patients. Separate DQALY survival plots are shown in which 0%, 25%, and 100% are assumed for the QOL (Fig. 4) . For this illustrative case the model predicts an initial survival advantage for the observation arm that is not significantly overcome by the delayed benefits of either the endovascular or surgical options for the remainder of the individual's life. A comparison of surgery and endovascular strategies is also shown in the change in the DQALY histogram (Fig.  5 ). This illustrates that for most simulated outcomes there is no change in DQALYs between undergoing endovascular and receivin surgical treatments.
For this example, in which 25% is used for the QOL with morbidity, surgery compared with endovascular treatment has a mean predicted DQALY change of 1.3 favoring surgery (95% CI Ϫ18 to 24.8; Table 2 ). For surgery compared with observation, the mean predicted DQALY change was 0, implying no strong trend in either direction (95% CI Ϫ17.9 to 13.4). For endovascular compared with observation treatment, the mean predicted DQALY change was Ϫ1.3 favoring observation (95% CI Ϫ24.7 to 13). These data and the model indicate that observation and surgery are both preferable to endovascular treatment. The confidence limits represent 2.5 and 97.5th percentiles for individual simulated cases. These limits represent more extreme cases such as death due to treatment or death due to early aneurysm rupture while the patient was under observation.
Probabilistic Sensitivity Analysis
A probabilistic sensitivity analysis was performed for the parameters surgical outcome, rupture outcome, and rupture rate for the sample cases in which we compared observation and surgery (Fig. 6 ). The variance in the mean change in DQALYs is most sensitive to the variance in the estimated rate of rupture because of the small sample size of the data source. Furthermore, within the range of predicted mean change in DQALYs lies strong support for both surgery and observation. In contrast, the variance in change in DQALYs is less sensitive to the outcome of rupture and of surgery. Further data about the rate of rupture of these aneurysms will have a pronounced effect on the confidence in the results of the model. Further data on the outcomes of aneurysm treatment and aneurysm rupture will have a smaller effect on the confidence in the results of the model. It is notable that the variance in the all-parameter analysis is similar to that in the rupture rate analysis. This further demonstrates the importance of the rupture rate to the overall variance of the model. The EVPI predictions are given in Table 3 . These provide a quantitative estimate of the variance in the output resulting from one or more variables. The highest EVPIs are associated with the variance in the annual rupture rate (Table 3) .
DISCUSSION
This tool addresses the limitations of published clinical decision analyses that were identified earlier. Our decision-analysis system can be adapted to individual patients. The inputs can be derived from large studies or specifical-N. Ghinea and J. M. van Gelder ly adjusted or selected for particular patients by the use of expert opinion. The values for QOL with morbidity and the discount rate can be adjusted according to the preferences of the patient. The model can be updated or improved and distributed over the Internet. Graphic presentations of the results complement summary statistics such as the mean change in DQALYs. Multiple methods are available for interactive sensitivity analysis. We are not aware of any comparable fully probabilistic and interactive medical decision-analysis systems that are accessible on the Internet. We originally conceived this project as an Internet site that would perform Monte Carlo simulations and return the results. The ubiquitous availability of Microsoft Excel and the advantages of using it as the interface for producing graphs were factors that caused us to write the program with Visual Basic for Applications. We are unaware of any previous use of DQALY survival graphs and histograms to express the results of simulations of thousands of patients. We are also unaware of any previous use of hierarchical simulations for probabilistic sensitivity analysis in medical decision models.
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Interactive, probabilistic decision analysis in unruptured aneurysm 5 Fig. 4 . Graphs depicting DQALY survival plots for the simulated outcome of both treatment and observation for the illustrative case described in Table 1 . It is important to note that the x axis represents DQALYs and not years. For this example the immediate cost of treatment compared with observation is never overcome by the delayed benefit. The rapid falloff after 20 years is caused by the increasing effects of discounting and the shape of the life expectancy distribution. In the upper panel we have used an intermediate value for QOL for morbidity of 25%. In the center panel we have used a QOL of 0% for morbidity, representing a morbidity-averse patient who places value only on full health and independence. In the lower panel we have used a QOL for morbidity of 100%, representing a death-averse patient who places value on life at all costs. The decision to treat is similar in outcome for the intermediate and death-averse patients. The morbidity-averse patients would be likely to choose observation rather than treatment. The most frequent value for change in DQALYs is 0 and is off the scale. This is to be expected because most aneurysms would not rupture under observation and most treatments for unruptured aneurysms would not cause morbidity or death. For the majority of patients the decision will not influence their quality or length of life. Fig. 6 . Graph showing the probabilistic sensitivity simulation results for comparing observation and surgery. The sensitivity analysis was performed separately for surgical outcome, rupture outcome, rupture rate, and all-way analysis (all of these factors combined). The rupture rate analysis generated the most variance (the widest distribution) for the mean change in DQALYs of any individual factor. To improve the overall confidence of the model results, the variance has to be reduced. Because the rupture rate contributes most to the variance, more data about this parameter will improve the confidence the most.
Data Entry
Users are required to enter estimates of major parameters for the decision model as probability distributions. Some users may not be familiar with statistical methods for deriving posterior distributions for parameters from clinical data or expert opinion. To produce a simple and consistent method for extracting distributions we ask users to provide the estimated parameter and the sample size. The program provides feedback on Bayesian posterior distributions, including the mean and 95% limits. We are not aware of any previous use of this method in interactive decision support systems. We have found in trials of this program that when they are unsure, users frequently enter a sample size of 100, from which the program derives the variance of the parameter. Where distributions are symmetrical, the variance will not affect the mean of the simulated outcomes. For asymmetrical distributions, the variance will affect the mean of simulated outcomes. Asymmetrical distributions are possible with small sample sizes. In contrast, the variance of the parameters will have a large effect on the probabilistic sensitivity analysis.
Sensitivity Analysis
Elementary one-way sensitivity analysis can be performed by varying any of the inputs and rerunning the simulation. Performed in this way, the importance of systematic bias in the estimates of parameters may be evaluated. This can be refined further to a one-way probabilistic sensitivity analysis by entering data normally for the parameter of interest and reducing all other parameters to virtual point estimates by artificially increasing their sample size. In this case, variance in the output will reflect both the variance from the parameter of interest and the individual outcomes for the simulated cases (such as variance from the actual time to aneurysm rupture or the variance from the life expectancy). A more sophisticated sensitivity analysis may be performed by using the multi-way hierarchical probabilistic sensitivity analysis facility. In this case the variance from the unselected parameters and the variance from individual outcomes is averaged out in the lowest level of the simulations. The higher level of the simulation then provides a distribution for the mean change in DQALYs. The variance in this distribution arises from a variance in the selected parameters for sensitivity analysis. Performed in this way, the importance of variance arising from small sample sizes or imprecise estimates can be explored. The user may examine the effect of one parameter selected, or he/she may examine the effects of removing one parameter at a time from the selected variables.
Expected Value of Perfect Information
The EVPI may be used to gauge the importance of variance in the estimates of the input parameters. When calculated for individual parameters it may be used to assess and compare the sensitivity of the model to the variance from each parameter. The EVPI quantifies the impact that further research into the selected parameters may potentially have on the decision. In the example described in this study, the EVPI for the aneurysm rupture rate substantially exceeds the EVPI for the outcome of aneurysm rupture and treatment. This indicates that further research into the annual rate of aneurysm rupture will be likely to have the greatest influence on the decision analysis. Further information is likely to affect significantly either one or both of the following: the results of the model and/or the confidence that may be placed in the results.
Further research on the morbidity and mortality rates related to aneurysm treatment will have a smaller influence. The EVPI is sensitive to systematic bias in the estimation of the input parameters. In this case the EVPI will be systematically biased. The effects of possible systematic bias are best assessed by one-way or two-way sensitivity analysis. A second interpretation of the EVPI is not illustrated here. The EVPI with all parameters selected may be contrasted with the EVPI with all selected except the parameter of interest, which is averaged out in the lower level of the simulation. This method produces the estimated change in overall EVPI with improved knowledge of the parameter of interest.
Complexity of the Decision
The decision to treat unruptured aneurysms is complex and depends on a number of separate sources of information as well as expert application of the information to individual cases. It is evident that quantitative calculations will assist rational decision making. In medical decision analysis, complex problems are divided into component pathways or branches. Risks are quantified, and a common utility is defined to compare outcomes with different life expectancies and QOLs. We have tried to present a model that incorporates the most important factors without becoming overly complex and alienating clinical users. Therefore, for this model we make a number of assumptions. A more complex model is technically easy to produce but would necessarily ask the user for inputs for which there is little meaningful data or expert opinion. Some important complexities that we have refrained from incorporating into the model are listed here.
1. With this model we assume a constant rate of rupture over time, and there is some evidence for this in the survival plots of observational studies. 14, 31 Alternatively, it has been proposed that aneurysms may have an early unstable period. 22 If the aneurysm rupture rate decreases over time, then the model will be biased toward treatment.
2. The model does not adjust the DQALYs for time spent undergoing treatment of aneurysms or recovering from ruptures. 13, 25 This will bias the model toward aneurysm treatment. 3. The model does not include rupture of aneurysms after treatment. There is a small risk of rupture after treatment with both clip placement and endovascular coil occlusion. 8, 28, 29 This will bias the model toward treatment. 4. The model does not incorporate a joint distribution correlating the outcome of rupture and the outcome of treatment. The user may simultaneously enter a high morbidity rate associated with both rupture and treatment for an individual patient because of known risk factors. Nevertheless, a high-risk patient in whom surgery is considered may also have a high risk of poor outcome from aneurysm rupture.
5. The model falls short of explicitly depicting many complex clinical scenarios. For example, there is currently no decision option for observing an aneurysm and treating it if it becomes larger. 16 There is also no capacity to model multiple aneurysms. These factors will bias the model toward early treatment. The model does not adjust the QALYs in the observation arm for the anxiety of living with an untreated aneurysm. This will bias the model toward observation. There is no capacity to incorporate the possibility for subsequent retreatment with coil occlusion or surgery. 4 There is no capacity for the model to incorporate the subsequent development of symptoms such as embolic events. 24 There is no capacity to model future improvements in technology. These last three would also bias the model toward observation.
6. The present model does not incorporate the projected financial costs of each outcome into a cost-effectiveness study.
Intended Use of the Model
We have not intended that the model be used to prescribe a decision choice for an individual. We expect the model to provide a framework for which an expert opinion is required for the final recommendation. The model may increase the confidence of the patient or the decision maker in their final decision.
Sources of Information
We advise great care and experienced judgment in extracting data from clinical studies for application to a specific patient. Clinical studies may describe a treatment series rather than a management series, and therefore may provide limited information on the selection of patients for treatment. Publication bias arises from the difference between clinical experiences and published clinical studies that often present small groups of patients or surprising or favorable findings. Publication bias may cause a bias toward treatment. Technological differences between the reported studies and the locally available methods and expertise may cause a bias toward treatment. Clinical studies usually present summaries of information that may not address the precise clinical question being posed or may not provide enough detailed stratification of the participants to enable the data to be applied to a specific patient. Studies of the outcome in patients with ruptured intracranial aneurysms usually describe hospital-based series rather than the results for a whole population. 11 These studies usually provide outcomes stratified by clinical features such as the level of consciousness at presentation with rupture. In contrast the important clinical features the age and the nature of the aneurysm when modeling decisions for patients with unruptured aneurysms.
Alternative Uses
The decision structure shown in Fig. 1 is not restricted to use in unruptured intracranial aneurysms. We envisage the model or its adaptations being used with other medical interventions that can be applied to asymptomatic individuals to prevent a catastrophic event that might otherwise occur.
Further Research
It has previously been shown that decision-tree methods and decision support systems may be useful in clinical practice for both clinicians and patients. 3, 23 Critical factors include the provision of information, speed and accessibility, simplicity, and adaptability. 3 Further research is required to determine whether the form of decision analysis presented here will be useful in clinical practice, particularly because we are unaware of any similar medical projects. 17 It remains to be shown whether the system will influence decision making, or whether it will have any significant use in the development of general policy, for application to individual cases, for communicating with patients, or for planning the most efficient medical research.
Further research is required into the appropriate level of complexity of the model. Further work is required in the critical appraisal of the literature and preparation of information for estimating patient-specific parameters. Further research is required to determine the best method for practitioners to express clinically uncertain parameters and to determine the best expression of the results of the simulations for human decision making.
CONCLUSIONS
We hope that the availability of models such as this will provide feedback to clinical researchers in the following ways: 1) by identifying the uncertain factors that have the greatest potential leverage on clinical decisions; 2) by defining the research questions for the quantitative decision maker; and 3) by showing the need for more detail and stratification of the results of clinical research.
